Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM

Indian Journal of Experimental Biology

Volumn 38, Issue 12, 2000, Pages 1207-1216

  Saha, S ^a   Mondal, S ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; GANGLIOSIDE; GANGLIOSIDE, GT1; IMMUNOGLOBULIN M; TUMOR ANTIGEN;

ANIMAL; ARTICLE; CARBOHYDRATE ANALYSIS; CHEMISTRY; DOSE RESPONSE; EHRLICH ASCITES TUMOR; IMMUNIZATION; IMMUNOLOGY; MALE; MOLECULAR GENETICS; MOUSE; PATHOLOGY; RABBIT;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, NEOPLASM; CARBOHYDRATE SEQUENCE; CARCINOMA, EHRLICH TUMOR; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GANGLIOSIDES; IMMUNIZATION; IMMUNOGLOBULIN M; MALE; MICE; MOLECULAR SEQUENCE DATA; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034503419     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Association of the glycolipid pattern with antigenic alterations in mouse fibroblasts transformed by murine virus
2. Glycolipid expression in lymphoma cell variants : Chemical quantity, immunologic reactivity and correlation with susceptibility to NK cells
3. Quantitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (Esb) potentials and isolation of a novel disialoganglioside (GD1α) from Eb cells
4. A ganglioside of rat ascites hepatoma AH7974F cells
5. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma
6. Identification of a neuroectodermal tumor antigen (OFA-1-2) as ganglioside GD2
7. Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid lines
8. Ganglioside GM2 as a human tumor antigen (OFA-I-1)
9. Localisation of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells
10. Amurine monoclonal antibody detecting N-actyl- and N-glycolyl-GM2 : Characterization of cell surface reactivity
11. Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against Fucosyl-GM1
12. Approaches to augmenting the immunogenicity of melanoma gangliosides from whole melanoma cells to ganglioside-KLH conjugate vaccine
13. Ganglioside expression in lung cancer cell lines
14. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells
15. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer
16. Shedding and immunoregulatory activity of YAC-1 lymphoma cells
17. Modulation of immune response by gangliosides: Inhibition of adherant monocyte accessory functions in vitro
18. Gangliosides shed by tumor cells enhance tumor formation in mice
19. Changes in plasma gangliosides in relation to tumor growth and their tumor enhancing effect
20. Effect of plasma gangliosides on the growth of Ehrlich ascites tumor
21. Characterization of gangliosides from Ehrlich ascites tumour cells and their variants
22. Detection and resolution of gangliosides in lipid extracts by thin layer chromatography
23. Optimal conditions for the aasay of fibroblast neuraminidase with different natural substrates
24. The purification and properties of β-galactosidase from bovine testis
25. Studies on glucosaminidase (testicular N-acetyl-β-glucosaminidase and N-actyl-β-galactosaminidase)
26. Production of high titer antisera against sialoglycosphingolipids and their characterization using sensitized liposome
27. Immunochemical studies with gangliosides
28. Immunogenicity of melanoma-associated gangliosides in cancer patients
29. An epitope common to ganglioside O-acetyl- GD3 and GD3 recognised by antibodies in melanoma patients after active specific immunotherapy
30. Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside
31. Analysis of the antibody response to immunization with purified O-acetyl GD3 ganglioside in patients with malignant melanoma
32. Therapy of mouse lymphoma with monoclonal antibodies to glycolipid : Selection of low antigenic variant in vivo
33. An IgG3 monoclonal antibody established after immunization with GM3 lactone : Immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo
34. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A phase I trial in patients with malignant melanoma
35. Regression of cutaneous metastatic melanoma by intralesional injection with human MA6 to ganglioside GD2
36. Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients
37. A phase I study of anti- GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage - Colony stimulating factor in patient with metastatic malanoma
38. Development of a human monoclonal antibody to ganglioside GM2 with potential for cancer treatment
39. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside
40. Anti-idiotype antibodies bear the internal image of a human tumor antigen
41. Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3
42. Immunization of melanoma patients withBEC2 anti-idiotype monoclonal antibody that mimics GD3 ganglioside : Enhanced immunogenicity when combined with adjuvant
43. Antibody response in melanoma patients immunized with an anti-idiotype antibody mimicing disialoganglioside GD2
44. Anti-tumor effect of internal image bearing anti-idiotypic monoclonal antibody in relation to GM3 ganglioside